Legal provisions of COM(2005)439 - Specific Programme to be carried out by means of direct actions by the Joint Research Centre under the 7th Framework Programme of the EC for research, technological development and demonstration activities (2007-2013)

Please note

This page contains a limited version of this dossier in the EU Monitor.

dossier COM(2005)439 - Specific Programme to be carried out by means of direct actions by the Joint Research Centre under the 7th Framework ...
document COM(2005)439 EN
date December 19, 2006


OJ L 312, 23.12.1995, p. 1. OJ L 292, 15.11.1996, p. 2. OJ L 136, 31.5.1999, p. 1.

Article 1

The Specific Programme related to the direct actions in research, technological development and demonstration to be carried out by the Joint Research Centre, hereinafter the 'Specific Programme' is hereby adopted for the period from 1 January 2007 to 31 December 2013.

Article 2

The Specific Programme shall establish the activities for the non-nuclear actions of the Joint Research Centre, providing customer driven scientific and technical support to the Community policy making process, ensuring support to the implementation and monitoring of existing policies and responding to new policy demands.

The objectives and the broad lines of those activities are set out in the Annex.

Article 3

In accordance with Annex II of the Framework Programme, the amount deemed necessary for the execution of the Specific Programme shall be EUR 1 751 million.

Article 4

1. All research activities carried out under the Specific Programme shall be carried out in compliance with fundamental ethical principles.

2. The following fields of research shall not be financed under this programme:

- research activity aiming at human cloning for reproductive purposes,

- research activity intended to modify the genetic heritage of human beings which could make such changes heritable1, research activities intended to create human embryos solely for the purpose of research or for the purpose of stem cell procurement, including by means of somatic cell nuclear transfer.

3. Research on human stem cells, both adult and embryonic, may be financed, depending both on the contents of the scientific proposal and the legal framework of the Member State(s) involved.

Any application for financing for research on human embryonic stem cells shall include, as appropriate, details of licensing and control measures that will be taken by the competent authorities of the Member States as well as details of the ethical approval(s) that will be provided.

As regards the derivation of human embryonic stem cells, institutions, organisations and researchers shall be subject to strict licensing and control in accordance with the legal framework of the Member State(s) involved.

Research relating to cancer treatment of the gonads may be financed.

4. The fields of research set out above shall be reviewed for the second phase of this programme (2010-2013) in the light of scientific advances.

Article 5

1. The Specific Programme shall be implemented by means of the direct actions as established in Annex III to the Framework Programme.

2. The rules for participation and dissemination relating to direct actions shall apply to the Specific Programme.

Article 6

1. The Commission shall draw up a multi-annual Work Programme for the implementation of the specific programme, setting out in greater detail the objectives and scientific and technological priorities set out in the Annex, and the timetable for implementation.

The multi-annual Work Programme shall take account of relevant research activities carried out by the Member States, Associated States and European and international organisations. It shall be updated where appropriate.

Article 7

The Commission shall arrange for the independent assessment provided for in Article 7 of the Framework Programme to be conducted concerning the activities carried out in the fields covered by the Specific Programme.

Article 8

This Decision shall enter into force on the third day following its publication in the Official Journal of the European Union.

This Decision is addressed to the Member States.